Skip to main content

Table 2 Concentration of CD44 expression before and after melatonin and placebo administration

From: Effect of melatonin supplementation in combination with neoadjuvant chemotherapy to miR-210 and CD44 expression and clinical response improvement in locally advanced oral squamous cell carcinoma: a randomized controlled trial

CD44

Median (range)

Melatonin (n = 13)

Placebo (n = 12)

p

Before

0.0349 (0.0048–0.1440)

0.0095 (0.0002–0.1170)

0.103

After

0.0115 (0.0003–0.2040)

0.0187 (0.0012–0.2780)

Difference (after − before)

− 0.0114 (− 0.0994 → + 0.1736)

0.0082 (− 0.1109 → + 0.2773)